U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07440511) titled 'Spleen Stiffness Measurement for the Detection of Advanced Fibrosis' on Jan. 07.
Brief Summary: Measurement of spleen stiffness (SSM) has shown potential as a complementary tool to liver stiffness measurement (LSM) for the assessment of portal hypertension in patients with MASLD, particularly in the setting of compensated advanced chronic liver disease (cACLD). The 100-Hz probe for SSM, developed more recently, improves the accuracy of spleen stiffness measurements by better capturing the specific characteristics of the splenic parenchyma. This method has been shown to correlate well with HVPG, the gold standard for the assessment o...